Lundbeck
HLUN-B.CO
#2582
Rank
C$7.72 B
Marketcap
$8.10
Share price
-0.98%
Change (1 day)
28.41%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Earnings for Lundbeck (HLUN-B.CO)

Earnings in 2024 (TTM): C$0.62 Billion

According to Lundbeck 's latest financial reports the company's current earnings are C$3.14 Billion. In 2023 the company made an earning of C$0.63 Billion, an increase over its 2022 earnings that were of C$0.52 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lundbeck from 2009 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) C$0.62 B-0.91%
2023 C$0.63 B21.69%
2022 C$0.52 B31.79%
2021 C$0.39 B-4.53%
2020 C$0.41 B-45.08%
2019 C$0.75 B-33.97%
2018 C$1.14 B12.76%
2017 C$1.01 B94.32%
2016 C$0.52 B-136.98%
2015 -C$1.42 Billion-1258.1%
2014 C$0.12 B-72.43%
2013 C$0.44 B4.31%
2012 C$0.42 B-55.26%
2011 C$0.94 B6.64%
2010 C$0.88 B-6.68%
2009 C$0.95 B